Literature DB >> 627753

Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity.

M Levy, M J Wexler.   

Abstract

Renal handling of sodium was studied in five dogs where an end-to-side portacaval fistula was constructed prior to the induction of cirrhosis with DMN. Such a model permits the effects of cirrhosis to be studied separately from the consequences of portal hypertension. Three control animals without cirrhosis maintained normal liver and kidney function and remained in sodium balance for as long as 8 weeks following surgery. In the five cirrhotic dogs, urinary sodium retention preceded ascites formation and was independent of hyperaldosteronism, hypoalbuminemia, hepatic ischemia, or decreased renal perfusion. Portal venous pressure remained normal in all cirrhotic dogs, and the splanchnic area remained free of venous collaterals. Plasma volume expansion also preceded ascites formation, and this variable increased by 8.4% (p less than 0.05) following 6 days of sodium retention. These temporal relationships between sodium retention, expanded plasma volume, and ascites formation are similar to those observed in ordinary cirrhotic dogs previously studied in this laboratory. Total plasma volume increased by 13.2% (p less than 0.05) when measured during the ascitic phase of cirrhosis. However, when the splanchnic and nonsplanchnic ("effective") components of plasma volume were measured by an exclusion technique, the ratio of these components to total plasma volume was not different from that observed in normal dogs. Thus no preferential consignment of retained salt and water had occurred. We conclude that urinary sodium retention in cirrhotic dogs occurs independently of portal hypertension or augmented splanchnic vascular capacity and is associated with expansion of the effective plasma volume, even though ascites is present.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 627753

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  11 in total

Review 1.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

Review 2.  Echocardiography in the Liver Transplant Patient.

Authors:  Parul Kakar; James Gubitosa; Christine Gerula
Journal:  Curr Cardiol Rep       Date:  2021-07-03       Impact factor: 2.931

3.  Renal sodium retention in liver disease.

Authors: 
Journal:  West J Med       Date:  1983-06

4.  Reduced activity of 11 beta-hydroxysteroid dehydrogenase in patients with cholestasis.

Authors:  C Quattropani; B Vogt; A Odermatt; B Dick; B M Frey; F J Frey
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

5.  Renal distal tubular handling of sodium in central fluid volume homoeostasis in preascitic cirrhosis.

Authors:  G Sansoè; A Ferrari; E Baraldi; C N Castellana; M C De Santis; F Manenti
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

6.  Total body water, extracellular water, plasma volume, and total body potassium in cirrhosis of the liver.

Authors:  O Schober; P Mariss; F W Schmidt; H Hundeshagen
Journal:  Klin Wochenschr       Date:  1979-08-01

Review 7.  New clues to the pathophysiology of hepatorenal failure.

Authors:  F Lang; W Gerok; D Häussinger
Journal:  Clin Investig       Date:  1993-02

8.  Factors that determine refractoriness of ascites to conventional therapy.

Authors:  S Amra; R Elie; I Kronborg
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

9.  Dogs with experimental cirrhosis of the liver but without intrahepatic hypertension do not retain sodium or form ascites.

Authors:  B Unikowsky; M J Wexler; M Levy
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

10.  Regulatory processes interacting to maintain hepatic blood flow constancy: Vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction.

Authors:  W Wayne Lautt
Journal:  Hepatol Res       Date:  2007-11       Impact factor: 4.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.